ALC Alcon Inc.
USHealthcareAs of 2026-07-10 16:00
Why ALC matters now
Alcon Inc. (ALC) is a US stock in Healthcare. The latest InvestLog snapshot shows $67.81 with +1.00% on the session and $33.07B in market capitalization; recent performance reads 1-month -2.41% and YTD -17.93%.
The latest financial table shown here is Q1 2026, with revenue of $2.65B, net income of $185.3M, and EPS of $0.38. Investors can compare that operating picture with valuation signals such as P/E 38.80 and FCF yield 5.2%.
The latest indexable market news headline is "Wall Street Analysts Predict a 27.75% Upside in Alcon (ALC): Here's What You Should Know" from Zacks Investment Research.
Additional event context on this page matters because analyst consensus is Buy with a median target of $78.00; recent congressional disclosure data includes Josh Gottheimer Sale. These signals are research inputs, not a recommendation.
Valuation
P/E (TTM)
38.80
PEG
—
P/B
1.42
P/S
2.98
EV/EBITDA
14.91
DCF Value
$79.36
FCF Yield
5.2%
Div Yield
0.6%
Margins & Returns
Gross Margin
54.9%
Operating Margin
12.3%
Net Margin
7.7%
ROE
3.7%
ROA
2.6%
ROIC
3.7%
Financials
| Period | Revenue | Net Income | EPS |
|---|---|---|---|
| Q1 2026 | $2.65B | $185.3M | $0.38 |
| Q4 2025 | $2.72B | $217.0M | $0.44 |
| FY 2025 | $10.40B | $980.0M | $1.98 |
| Q3 2025 | $2.61B | $237.0M | $0.48 |
Analyst Ratings
Consensus
Buy
Target (Consensus)
$81.67
Target (Median)
$78.00
Target Range
$70.00 - $97.00
Trading Activity
Congress Trades
Related Stocks
Latest News
Company Info
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Country
CH
Exchange
—
Beta
0.70
Alcon Inc. is a global leader in eye care, engaging in the comprehensive lifecycle of ophthalmic solutions, from initial research and development to manufacturing, distribution, and worldwide sales. Its diverse portfolio serves both eye care professionals and the patients they treat across the globe. The company's operations are divided into two main segments: 1. Surgical Segment: This division provides a vast array of products crucial for ophthalmic surgical procedures. Offerings encompass advanced equipment, sophisticated diagnostic tools, and implantable devices such as intraocular lenses (IOLs). It also supplies essential consumables, including viscoelastics, specialized surgical solutions, incisional instruments, and custom surgical procedure packs. Key product areas within this segment feature: Cataract Management: Technologies like the Centurion Vision System, LenSx femtosecond laser, LuxOR surgical ophthalmic microscope, NGENUITY 3D visualization system, and the ORA system for intra-operative measurements, along with custom pak surgical procedure kits. Vitreoretinal Interventions: Including Constellation Vision Systems, procedure packs, lasers, hand-held microsurgical instruments (such as grieshaber and MIVS), a range of scissors, forceps, micro-instruments, medical-grade vitreous tamponades, and Hypervit vitrectomy probes. Refractive Correction: WaveLight lasers and Contoura Vision, specifically utilized for LASIK treatments. Glaucoma Solutions: The EX-PRESS glaucoma filtration device. Advanced Implantables: Such as AcrySof IQ IOLs, which include both monofocal IOLs and cutting-edge technology IOLs marketed under the PanOptix and ReSTOR brands, designed to correct presbyopia and astigmatism during cataract surgery. 2. Vision Care Segment: This segment delivers products aimed at daily vision needs and overall ocular health. Its offerings include daily disposable, reusable, and color-enhancing contact lenses. Furthermore, it provides a variety of eye health products addressing issues like dry eye, glaucoma, contact lens maintenance, and ocular allergies, alongside eye vitamins and redness relievers. These are available under prominent brands such as TOTAL, PRECISION, DAILIES AquaComfort PLUS, Air Optix, Opti-Free, Clear Care, Tears Naturale, Genteal, ICAPS, and Vitalux. Established in 1945, Alcon Inc. changed its name from Alcon Universal S.A. to its current designation in December 2001. The company's corporate headquarters are located in Geneva, Switzerland.